Volume | 303,207 |
|
|||||
News | - | ||||||
Day High | 33.98 | Low High |
|||||
Day Low | 32.62 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Harmony Biosciences Holdings Inc | HRMY | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
33.52 | 32.62 | 33.98 | 33.58 | 33.52 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
6,947 | 303,207 | $ 33.48 | $ 10,152,407 | - | 18.6112 - 39.265 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:01:46 | 5 | $ 31.74 | USD |
Harmony Biosciences Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.91B | 56.77M | - | 582.02M | 128.85M | 2.27 | 14.79 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Harmony Biosciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HRMY Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 33.95 | 34.44 | 31.76 | 33.09 | 254,812 | -0.37 | -1.09% |
1 Month | 33.89 | 34.44 | 29.35 | 31.69 | 422,601 | -0.31 | -0.91% |
3 Months | 31.47 | 35.395 | 29.35 | 32.08 | 355,775 | 2.11 | 6.70% |
6 Months | 33.80 | 35.395 | 18.6112 | 28.24 | 568,708 | -0.22 | -0.65% |
1 Year | 34.00 | 39.265 | 18.6112 | 31.40 | 632,686 | -0.42 | -1.24% |
3 Years | 29.16 | 62.085 | 18.6112 | 38.83 | 512,865 | 4.42 | 15.16% |
5 Years | 36.50 | 62.085 | 18.6112 | 38.74 | 455,823 | -2.92 | -8.00% |
Harmony Biosciences Description
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. |